Table 3.
Univariate and multivariate analysis of variables associated with achievement of DAPSA low disease activity and remission at 12 months.
| Univariate Analysis | Multivariate Analysis | |||||
|---|---|---|---|---|---|---|
| Variable | OR | 95% CI | p | OR | 95% CI | p |
| Age | 0.999 | 0.98–1.018 | 0.906 | |||
| Smoke | 1.181 | 0.621–2.247 | 0.613 | |||
| Sex | 1.309 | 0.820–2.087 | 0.259 | |||
| BMI | 0.980 | 0.929–1.033 | 0.457 | |||
| Relevant comorbidity | 1.299 | 0.818–2.064 | 0.267 | |||
| Disease duration | 1.002 | 0.998–1.006 | 0.289 | |||
| Baseline DAPSA | 0.908 | 0.881–0.937 | <0.0001 | 0.911 | 0.883–0.939 | <0.0001 |
| Concomitant csDMARD | 1.577 | 0.871–2.856 | 0.133 | |||
| Number of previous bDMARD | 0.84 | 0.691–1.022 | 0.0815 | 0.856 | 0.691–1.061 | 0.156 |
| Number of previous csDMARD | 1.328 | 1.021–1.726 | 0.034 | 1.342 | 1.003–1.795 | 0.048 |
OR odds ratio, CI confidence interval, BMI body mass index, DAPSA Disease Activity index for Psoriatic Arthritis.